Home/Filings/4/0001181431-10-012246
4//SEC Filing

Berry Barbara 4

Accession 0001181431-10-012246

CIK 0001459450other

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 5:21 PM ET

Size

8.0 KB

Accession

0001181431-10-012246

Insider Transaction Report

Form 4
Period: 2010-02-24
Berry Barbara
SVP, Human Resources
Transactions
  • Exercise/Conversion

    Common Stock

    2010-02-24$3.96/sh+526$2,08317,284 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2010-02-245260 total
    Exercise: $3.96Exp: 2010-06-20Common Stock (526 underlying)
Footnotes (3)
  • [F1]Includes 1,336 shares acquired under the Issuer's Employee Stock Purchase Plan on December 1, 2009.
  • [F2]The option was issued in connection with the spin-off of the Issuer by Myriad Genetics, Inc. ("MGI") on 06/30/09, pursuant to which each outstanding MGI option was converted into an adjusted MGI option, exercisable for the same number of shares of common stock as the original MGI option, and a new Issuer option, exercisable for one-fourth of the number of shares of common stock as the original MGI option. An adjusted exercise price of each converted option was determined in accordance with Section 409A and Section 422 of the Internal Revenue Code of 1986. All other terms of the converted options remain the same however; the vesting and expiration is based on the optionholder's continuing employment with MGI or the Issuer, as applicable, following the spin-off. The original MGI option was granted on 06/20/00 (the "Date of Grant").
  • [F3]The option vested over a five-year period as to 20% of the shares on each anniversary of the Date of Grant.

Issuer

Myriad Pharmaceuticals, Inc.

CIK 0001459450

Entity typeother

Related Parties

1
  • filerCIK 0001465780

Filing Metadata

Form type
4
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:21 PM ET
Size
8.0 KB